Suresh Babu CV, Ravindra Gudihal, Sundaram Palaniswamy M, … · 2016-09-11 · ASMS 2015 ThP 517...
4
ASMS 2015 ThP 517 Peptide Mapping of Antibody Drug Conjugate Using CE-ESI-MS Suresh Babu CV, Ravindra Gudihal, Sundaram Palaniswamy M, Nilanjan Guha and Sudha Rajagopalan; Agilent Technologies India Pvt. Ltd., Bangalore, India ASMS 2015 Page 1
Transcript of Suresh Babu CV, Ravindra Gudihal, Sundaram Palaniswamy M, … · 2016-09-11 · ASMS 2015 ThP 517...
![Page 1: Suresh Babu CV, Ravindra Gudihal, Sundaram Palaniswamy M, … · 2016-09-11 · ASMS 2015 ThP 517 Peptide Mapping of Antibody Drug Conjugate Using CE-ESI-MS Suresh Babu CV, Ravindra](https://reader033.fdocuments.us/reader033/viewer/2022042323/5f0d34057e708231d4392e1e/html5/thumbnails/1.jpg)
ASMS 2015
ThP 517
Peptide Mapping of
Antibody Drug Conjugate
Using CE-ESI-MS
Suresh Babu CV, Ravindra Gudihal,
Sundaram Palaniswamy M, Nilanjan
Guha and Sudha Rajagopalan; Agilent
Technologies India Pvt. Ltd.,
Bangalore, India
ASMS 2015 Page 1
![Page 2: Suresh Babu CV, Ravindra Gudihal, Sundaram Palaniswamy M, … · 2016-09-11 · ASMS 2015 ThP 517 Peptide Mapping of Antibody Drug Conjugate Using CE-ESI-MS Suresh Babu CV, Ravindra](https://reader033.fdocuments.us/reader033/viewer/2022042323/5f0d34057e708231d4392e1e/html5/thumbnails/2.jpg)
Peptide Mapping of Antibody Drug Conjugate Using CE-ESI-MS
ASMS 2015 Page 2
![Page 3: Suresh Babu CV, Ravindra Gudihal, Sundaram Palaniswamy M, … · 2016-09-11 · ASMS 2015 ThP 517 Peptide Mapping of Antibody Drug Conjugate Using CE-ESI-MS Suresh Babu CV, Ravindra](https://reader033.fdocuments.us/reader033/viewer/2022042323/5f0d34057e708231d4392e1e/html5/thumbnails/3.jpg)
Peptide Mapping of Antibody Drug Conjugate Using CE-ESI-MS
ASMS 2015 Page 3
![Page 4: Suresh Babu CV, Ravindra Gudihal, Sundaram Palaniswamy M, … · 2016-09-11 · ASMS 2015 ThP 517 Peptide Mapping of Antibody Drug Conjugate Using CE-ESI-MS Suresh Babu CV, Ravindra](https://reader033.fdocuments.us/reader033/viewer/2022042323/5f0d34057e708231d4392e1e/html5/thumbnails/4.jpg)
Peptide Mapping of Antibody Drug Conjugate Using CE-ESI-MS
ASMS 2015 Page 4